Laurel Wealth Advisors LLC Teva Pharmaceutical Industries LTD Transaction History
Laurel Wealth Advisors LLC
- $617 Million
- Q3 2024
A detailed history of Laurel Wealth Advisors LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Laurel Wealth Advisors LLC holds 569 shares of TEVA stock, worth $12,569. This represents 0.0% of its overall portfolio holdings.
Number of Shares
569
Previous 236
141.1%
Holding current value
$12,569
Previous $3,000
233.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TEVA
# of Institutions
625Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$950 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$801 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$763 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$637 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$585 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $24.5B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...